Evaluation of chemotherapy in children with metastatic Ewing's sarcoma and osteogenic sarcoma.
D000293:Adolescent; D000588:Amines / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D009362:Neoplasm Metastasis / Q000188:drug therapy; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D012516:Osteosarcoma / Q000188:drug therapy*; D012512:Sarcoma, Ewing / Q000188:drug therapy*; D014227:Triazines / Q000627:therapeutic use; D014499:Uracil Mustard / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000588:Amines; D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D014227:Triazines; D014750:Vincristine; D003520:Cyclophosphamide; D008558:Melphalan; D014499:Uracil Mustard; D006918:Hydroxyurea; D003630:Daunorubicin